Isle of Man vs State of Palestine: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Isle of Man
0.0%
in 2024
State of Palestine
0.0%
in 2024
Isle of Man rank
167th
State of Palestine rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Isle of Man
- State of Palestine
How they compare
Isle of Man currently reports 0.0% against 0.0% in State of Palestine, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was State of Palestine ahead.
Isle of Man ranks 167th and State of Palestine ranks 167th of 246 countries.
Isle of Man has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Isle of Man | State of Palestine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.0% | 0.0% | Isle of Man |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Isle of Man or State of Palestine?
- Isle of Man, at 0.0% against 0.0% in State of Palestine as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Isle of Man and State of Palestine?
- 0.0%, with Isle of Man ahead.
- How many years of comparable data are there for Isle of Man and State of Palestine?
- 10 years are reported by both, from 2015 to 2024.
- How do Isle of Man and State of Palestine rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Isle of Man ranks 167th and State of Palestine ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.